Westview Management dba Westview Investment Advisors

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2073768 BURLINGTON, VT

Position in VRTX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$2,970,942

+$356,897 QoQ

Shares Held

5,981

+2.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

2.94%

of 13F equity value

Holder Rank

#586

of 1,735 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Westview Management dba Westview Investment Advisors holds $6,160,211 across 3 Biotechnology names. VRTX ranks #1 (48.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	5,981	$2,970,942
2	TGTX	Tg Therapeutics, Inc.	29,224	$1,605,566
3	ARGX	Argenx SE	1,707	$1,583,703

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,970,942	5,981	+2.2%	Shares	Sole	2026-07-31
2026-03-31	$2,614,045	5,854	-6.8%	Shares	Sole	2026-05-08
2025-12-31	$2,848,914	6,284	—	Shares	Sole	2026-01-09
No filing history on record for this holder in this stock.